(URGN) Urogen Pharma complete technical analysis [charts+indicators] | Buy/Sell Urogen Pharma | (URGN) share price targets
Complete technical analysis of Urogen Pharma (URGN) by charts plus indicators, forecast predictions and share price targets for Urogen Pharma (URGN)
Urogen Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-04-09 View latest technical analysis
10 day averaged volume of Urogen Pharma is 276620
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Tue Apr 2024 | 13.37 | 13.32 | 13.91 | 13.21 | 0.738 times |
| 08 Mon Apr 2024 | 13.21 | 13.64 | 13.64 | 13.18 | 0.453 times |
| 05 Fri Apr 2024 | 13.60 | 13.54 | 13.98 | 13.21 | 0.465 times |
| 04 Thu Apr 2024 | 13.64 | 13.77 | 14.30 | 13.50 | 0.855 times |
| 03 Wed Apr 2024 | 13.66 | 14.00 | 14.26 | 13.47 | 0.637 times |
| 02 Tue Apr 2024 | 14.09 | 14.28 | 14.52 | 13.00 | 0.702 times |
| 01 Mon Apr 2024 | 14.20 | 14.75 | 14.75 | 14.16 | 0.706 times |
| 28 Thu Mar 2024 | 15.00 | 14.92 | 15.25 | 14.56 | 0.635 times |
| 27 Wed Mar 2024 | 14.96 | 15.59 | 15.67 | 14.46 | 0.9 times |
| 26 Tue Mar 2024 | 15.17 | 16.80 | 16.85 | 14.99 | 1.41 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 13.6, but if it comes above 13.6, then a intra day buy could be more profitable.
If you take a sell trade below 13.6, then use 13.6 as stoploss and 12.1 as target. However if you take a buy trade in stock , then use 13.6 as stoploss and 14.83 as target.
Share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Target | 12.76 |
| Upside Target | 13.83 |
| Upside Target | 14.46 |
| Upside Target | 14.75 |
| Upside Target | 15.40 |
| Upside Target | 16.17 |
| Upside Target | 16.32 |
| Upside Target | 16.45 |
| Upside Target | 18.23 |
| Upside Target | 18.29 |
| Upside Target | 18.63 |
| Upside Target | 19.87 |
Intraday share price targets for Urogen Pharma (URGN)
| Target Type | Value |
| Downside Intraday Target | 13.06 |
| Downside Intraday Target | 12.76 |
| Upside Intraday Target | 13.79 |
| Upside Intraday Target | 14.22 |
| Upside Intraday Target | 13.49 |
Weekly technical analysis of Urogen Pharma (URGN)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Tue Apr 2024 | 13.37 | 13.64 | 13.91 | 13.18 | 0.354 times |
| 05 Fri Apr 2024 | 13.60 | 14.75 | 14.75 | 13.00 | 0.544 times |
| 28 Thu Mar 2024 | 15.00 | 16.19 | 18.23 | 14.46 | 0.499 times |
| 22 Fri Mar 2024 | 15.76 | 14.50 | 16.17 | 13.83 | 2.028 times |
| 15 Fri Mar 2024 | 14.46 | 18.10 | 18.29 | 13.86 | 1.269 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Urogen Pharma (URGN)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Tue Apr 2024 | 13.37 | 14.75 | 14.75 | 13.00 | 0.148 times |
| 28 Thu Mar 2024 | 15.00 | 17.32 | 18.63 | 13.83 | 1.155 times |
| 29 Thu Feb 2024 | 18.33 | 15.76 | 19.87 | 15.40 | 1.398 times |
| 31 Wed Jan 2024 | 15.70 | 14.97 | 16.45 | 13.40 | 0.833 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Urogen Pharma (URGN)
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
Urogen Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.24 and Urogen Pharma (URGN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Urogen Pharma ( (URGN) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Urogen Pharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Urogen Pharma in short term and the sell signal is strong.
Urogen Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.24 and Urogen Pharma (URGN) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Urogen Pharma (URGN) stock. Volume based technical analysis of Urogen Pharma (URGN) stock is negative.
Urogen Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.